Zevra Therapeutics is a rare disease therapeutics company that focuses on developing therapies targeting significant unmet medical needs, specifically in areas like Niemann-Pick Disease Type C and sleep disorders.

Zevra Therapeutics develops therapies for rare diseases, specifically focusing on unmet patient needs. The company is self-described as pursuing a nimble and data-driven approach to therapeutics.

Zevra Therapeutics

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With unique, data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

COM:ZEVRA

Zevra Therapeutics

Last Close

9.13

22/11 21:00

Market Cap

511.61M

Beta: -

Volume Today

664.21K

Avg: -

Analysis Not Available